CN108354851A - 小分子肽健肤膏 - Google Patents
小分子肽健肤膏 Download PDFInfo
- Publication number
- CN108354851A CN108354851A CN201810369425.8A CN201810369425A CN108354851A CN 108354851 A CN108354851 A CN 108354851A CN 201810369425 A CN201810369425 A CN 201810369425A CN 108354851 A CN108354851 A CN 108354851A
- Authority
- CN
- China
- Prior art keywords
- skin
- vitamin
- small
- grams
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 5
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 10
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 6
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000011187 glycerol Nutrition 0.000 claims abstract description 6
- 229920002545 silicone oil Polymers 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 5
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 5
- 239000011718 vitamin C Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 230000000694 effects Effects 0.000 abstract description 7
- 230000037303 wrinkles Effects 0.000 abstract description 7
- 208000003351 Melanosis Diseases 0.000 abstract description 6
- 230000009759 skin aging Effects 0.000 abstract description 6
- 230000037394 skin elasticity Effects 0.000 abstract description 6
- 208000001034 Frostbite Diseases 0.000 abstract description 3
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 210000003205 muscle Anatomy 0.000 abstract description 2
- 206010034754 petechiae Diseases 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 description 7
- 238000012423 maintenance Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003163 gonadal steroid hormone Substances 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 229940023462 paste product Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- -1 pre- anti-cancer Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
小分子肽健肤膏是经多年研制，试用验证后选用：低聚肽、甘油、硅油、维生素C、维生素E组成，本发明配伍合理，组方中各原料协同作用，具有减少皱纹、恢复皮肤弹性、祛斑、减缓皮肤老化等优点，长期使用可使肌肤白皙、容颜娇美、保持青春的容貌，对烧伤、冻伤、毛细血管出血等方面有很好的效果，多年试用，受到广大人们的一致好评。
Description
技术领域：
本发明是一种滋润保养肌肤的外用膏剂产品。
背景技术：
现有一些滋润保养肌肤的产品，都有这样或那样的缺陷和不足，达不到减少皱纹、恢复皮肤弹性、祛斑、减缓皮肤老化等优点的效果。
发明内容：
本发明的目的是在克服现有一些滋润保养肌肤的产品的缺陷和不足，提供一种能达到减少皱纹、恢复皮肤弹性、祛斑、减缓皮肤老化等优点效果的滋润保养肌肤的外用膏剂产品。
具体实施方式：
本发明的组方是：低聚肽：8-20克、甘油：50-200克、硅油：8-20克、维生素C：50-150毫克、维生素E：8-20毫克。
本发明的优选组方是：低聚肽：10克、甘油：80克、硅油：10克、维生素C：60毫克、维生素E：15毫克。
制做方法：
按照上述组方中重量配比的原料投入，按照现代膏剂的工艺制做方法制成膏，每支重40克。
本发明组方中，低聚肽：增强巨噬细胞的吞噬能力和红细胞免疫功能、增加淋巴细胞功能，促使粪便排泄，降低血清胆固醇浓度，抑制脂肪的积蓄，抑制有害菌，排除毒素，提高免疫力；甘油：美白补水，用于全身补水滋润；硅油：保护、滋润皮肤、治疗皮炎、湿疹；维生素C：抗氧化，抗自由基，抑制酪氨酸酶的形成、美白、淡斑、解毒、预防癌症，能阻断致癌物亚硝酸铵的形成，有使吞噬细胞降低吞噬能力的作用，对缓解白癜风、降低癌症发病有防治的作用；维生素E：延缓衰老，有效减少皱纹的产生，保持青春的容貌，减少细胞耗氧量，使人更有耐久力，有助减轻腿抽筋和手足僵硬的状况，抗氧化保护机体细胞免受自由基的毒害，改善脂质代谢，预防冠心病、动脉粥样硬化，预防癌症，有效抑制肿瘤生长，预防多处慢性疾病，预防炎症性皮肤病、脱发症，预防溶血性贫血、保护红血球使之不容易破裂；预防治疗甲状腺疾病，改善血液循环、保护组织、降低胆固醇、预防高血压，预防与治疗静脉曲张，防止血液的凝固，减少斑纹组织的产生，强化肝细胞膜、保护肺泡细胞，降低肺部及呼吸系统遭受感染的几率，保护皮肤免受紫外线和污染的伤害，减少疤痕与色素的沉积，加速伤口的愈合，促进性激素分泌，使男子精子活力和数量增加，使女子雌性激素浓度增高，提高生育能力，预防流产，还发现维生素E可抑制眼睛晶状体内的过氧化脂反应，使末稍血管扩张，改善血液循环，预防近视发生和发展，促进性激素分泌，治疗先兆流产和习惯性流产，对防治男性不育症也有一定帮助，还有，保护T淋巴细胞、保护红细胞、抗自由基氧化、抑制血小板聚集，从而降低心肌梗死和脑梗塞的危险性，对烧伤、冻伤、毛细血管出血、更年期综合症、美容等方面都有很好的效果。
本发明配伍合理，组方中各原料协同作用，具有减少皱纹、恢复皮肤弹性、祛斑、减缓皮肤老化等优点，长期使用可使肌肤白皙、容颜娇美、保持青春的容貌，对烧伤、冻伤、毛细血管出血等方面有很好的效果，多年试用，受到广大人们的一致好评。
本发明是外用膏剂，每天1-2次，视皮肤面积大小而取量。
近年耒，本发明选取120名20--55岁年龄段的女性作为试用对象，对本发明进行评估，评估方法采用民意认定，非常滿意表示极好，滿意表示很好，能够接受表示好，一般表示不乐意接受。
选取120名20--55岁年龄段的女性作为试用对象，其中：
减少皱纹试用对象：42名，非常滿意36名，滿意6名；
恢复皮肤弹性试用对象：48名，非常滿意41名，滿意7名；
祛斑试用对象：12名，非常滿意10名，滿意2；
减缓皮肤老化试用对象：18名，非常滿意15名，滿意3名；
由上述数据可见，本发明对减少皱纹、恢复皮肤弹性、祛斑、减缓皮肤老化具有很好的效果。
Claims (2)
1.小分子肽健肤膏，其特征在于它是由下述重量配比的原料制成的：低聚肽：8-20克、甘油：50-200克、硅油：8-20克、维生素C：50-150毫克、维生素E：8-20毫克。
2.根据权利要求1所述的小分子肽健肤膏，其特征在于它的优选组方是：低聚肽：10克、甘油：80克、硅油：10克、维生素C：60毫克、维生素E：15毫克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810369425.8A CN108354851A (zh) | 2018-04-24 | 2018-04-24 | 小分子肽健肤膏 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810369425.8A CN108354851A (zh) | 2018-04-24 | 2018-04-24 | 小分子肽健肤膏 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108354851A true CN108354851A (zh) | 2018-08-03 |
Family
ID=63008958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810369425.8A Pending CN108354851A (zh) | 2018-04-24 | 2018-04-24 | 小分子肽健肤膏 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108354851A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721340A (zh) * | 2009-10-23 | 2010-06-09 | 无限极（中国）有限公司 | 一种用于延缓肌肤衰老的化妆品组合物 |
| CN103126916A (zh) * | 2011-11-25 | 2013-06-05 | 株式会社爱茉莉太平洋 | 从大豆中分离并制备小分子肽的方法和化妆品组合物 |
| CN104856892A (zh) * | 2014-11-14 | 2015-08-26 | 广州远想生物科技有限公司 | 一种富含生长因子的化妆品或护肤品制剂及其制备方法 |
| CN105380816A (zh) * | 2015-12-14 | 2016-03-09 | 北京肽康生物科技有限公司 | 生物活性肽在化妆品制备中的用途 |
| CN105878131A (zh) * | 2016-06-08 | 2016-08-24 | 广州市创美时美容化妆品有限公司 | 一种含有植物细胞活性物和多肽的抗衰老化妆品组合物 |
-
2018
- 2018-04-24 CN CN201810369425.8A patent/CN108354851A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721340A (zh) * | 2009-10-23 | 2010-06-09 | 无限极（中国）有限公司 | 一种用于延缓肌肤衰老的化妆品组合物 |
| CN103126916A (zh) * | 2011-11-25 | 2013-06-05 | 株式会社爱茉莉太平洋 | 从大豆中分离并制备小分子肽的方法和化妆品组合物 |
| CN104856892A (zh) * | 2014-11-14 | 2015-08-26 | 广州远想生物科技有限公司 | 一种富含生长因子的化妆品或护肤品制剂及其制备方法 |
| CN105380816A (zh) * | 2015-12-14 | 2016-03-09 | 北京肽康生物科技有限公司 | 生物活性肽在化妆品制备中的用途 |
| CN105878131A (zh) * | 2016-06-08 | 2016-08-24 | 广州市创美时美容化妆品有限公司 | 一种含有植物细胞活性物和多肽的抗衰老化妆品组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Matwiejczuk et al. | Review of the safety of application of cosmetic products containing parabens | |
| US11571373B2 (en) | Skin care preparations for babies | |
| CN108186394B (zh) | 一种舒敏修护滋养面膜精华及制备方法 | |
| CN104434731B (zh) | 一种营养滋润型护手霜及其制备方法 | |
| CN102973486B (zh) | 一种滋养驻颜洗面奶及其制备方法 | |
| JPH10500396A (ja) | 皮膚病を予防かつ治療するための衛生用及び化粧製剤、及びそれを得るための方法 | |
| CN106309317A (zh) | 一种营养抗皱精华液 | |
| CN105560155A (zh) | 含有山羊奶的化妆品组合物及其应用 | |
| CN112245363A (zh) | 一种丹参美白祛斑面膜 | |
| CN113509408A (zh) | 一种护肤复合精华油 | |
| CN104434642B (zh) | 一种晒后修护美白保湿凝露及其制备方法 | |
| JP2000128765A (ja) | 皮膚化粧料 | |
| CN109248117A (zh) | 含菠萝蛋白酶、假叶树、葡萄籽、山金车和香蜂草的化妆品组合物 | |
| JP6232180B2 (ja) | 烏梅抽出物を含む皮膚刺激緩和用組成物 | |
| CN104188859B (zh) | 一种含天然成分提取物的抗皱嫩肤乳液及其制备方法 | |
| US20170196797A1 (en) | Composition containing glycine gracilis oil | |
| JP4768097B2 (ja) | 活性酸素消去剤、血小板凝集抑制剤、皮膚化粧料および浴用剤 | |
| CN108354851A (zh) | 小分子肽健肤膏 | |
| CN104922008A (zh) | 一种除色斑精华素 | |
| JP2008273922A (ja) | 皮膚外用剤および粘膜外用剤 | |
| CN104188808B (zh) | 一种祛斑祛黄凝胶及其制备方法 | |
| RU2671511C1 (ru) | Косметическая композиция для ухода за волосами и кожей головы (варианты) | |
| CN102973451A (zh) | 一种芦荟润肤霜及其制备方法 | |
| KR20160081176A (ko) | 카테킨 및 파낙시돌을 함유하는 보습용 또는 미백용 피부 외용제 조성물 | |
| US20170035802A1 (en) | Method for treating itching |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Huang Xianchao Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Huang Xianchao Document name: Notification of Publication and of Entering the Substantive Examination Stage of the Application for Invention |
|
| DD01 | Delivery of document by public notice |
Addressee: Huang Xianchao Document name: the First Notification of an Office Action |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Huang Xianchao Document name: Deemed as a notice of withdrawal |
|
| DD01 | Delivery of document by public notice | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180803 |
|
| WD01 | Invention patent application deemed withdrawn after publication |